News | December 28, 2023
Elpiscience and Astellas collaborate for novel bispecific macrophage engager
Elpiscience will receive up to US $37 million, including the upfront payment and license option fees
Elpiscience will receive up to US $37 million, including the upfront payment and license option fees
Lonza supports development and manufacturing of ABL Bio’s bispecific antibody candidate with a complete and integrated end-to-end solution
The product is backed by required scientific proof and comparative bioequivalence studies
Recognition illustrates Takeda’s patient-centricity throughout its manufacturing and supply processes
The expansion reiterates BASF’s continued commitment to Asia Pacific and specifically to customers in the medical glove industry
Zerion´s innovative Dispersome technology builds on a new concept of increasing drug solubility by using natural protein-based excipients to formulate APIs into amorphous solid dispersions (ASDs) by spray drying
Immatics to receive upfront payment of US $ 150 million and additional milestone payments of up to US $ 770 million plus tiered double-digit royalties on net product sales
High-resolution image-based ART workflow software uses artificial intelligence to provide objective embryo grading, to assist embryologists during embryo selection
The safety profile of the Lunsumio and Polivy combination was consistent with the known profiles of the individual study medicines
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
